Clinical trial
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
NCT01997190
Study timeline
Study start (unknown)2013-10-01Date precision: month
Registry last updated2023-08-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Malignant Pleural Effusionunresolved
Lung Cancerunresolved
Mesotheliomaunresolved
Breast Cancerunresolved
Ovarian Cancerunresolved
Interventions
AdV-tk + valacyclovirBIOLOGICAL
Sponsors & collaborators
Candel Therapeutics, Inc.lead sponsor
University of Pennsylvaniacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01997190 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.